| 发明名称 |
Pharmaceutical composition comprising cxcr3 inhibitor |
| 摘要 |
A pharmaceutical composition for the treatment of cancer of which survival and/or metastasis is under the influence of signal transduction mediated by a chemokine receptor CXCR3, which comprises an agent to inhibit CXCR3, and a method of treatment and diagnosis of such cancer.
|
| 申请公布号 |
US2009208486(A1) |
申请公布日期 |
2009.08.20 |
| 申请号 |
US20050591817 |
申请日期 |
2005.03.09 |
| 申请人 |
TAKETO MAKOTO;KAWADA KENJI |
发明人 |
TAKETO MAKOTO;KAWADA KENJI |
| 分类号 |
A61K39/395;A61K31/7088;A61K31/7105;A61K45/00;A61K48/00;A61P35/00;A61P35/04;A61P43/00;C07K16/28;G01N33/53 |
主分类号 |
A61K39/395 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
